Summit Therapeutics Share Discussion Threads

[football] 20/1/2017 17:29

So if this comes up Trumps no pun intended I've got to travel around the world for 5 years before I come back to my stately home to pay no tax. I got excited there when you said no tax after 5 years

[waterloo01] 20/1/2017 17:25

Good summary macmoss and very thankful for SIPP's and ISA's as can just ignore it (although this changes if you file outside UK, where they often don't recognise their tax free status).

[macmoss] 20/1/2017 17:21

Rules on Capital gains has changed many times. At the moment residents in the UK pay Capital gains tax on profits made from selling shares no matter how long they have been held. Only non-residents pay no capital gains tax provided they don't return to the UK within 5 years of first leaving. The rate of Capital gains tax is dependent on ones tax band, so Capital gains tax rate will be charged at 10% or 20%, after deductions of any losses and taking account of the annual Capital gains tax allowance of £11,100.

[chrisatrdg] 20/1/2017 17:21

The level of investment today in one day,I think,is unprecedented & which because the total shares in two tranches (assuming they are the same) exceeds 3% we will soon know who they are.

It now looks to me that we are now getting the re-rating that this share deserves.

Fingers crossed for next week.

[waterloo01] 20/1/2017 17:18

Cautiousmoney, if they were to change listing, it's more likely to be as a US company on Nasdaq, especially in todays environment, than a full listing on the LSE.

If the £2m+ buys are an II, then assume they will be in for the ride!

[hugus maximus] 20/1/2017 17:05

What a solid and encouraging day!

I'm assuming this is not some significant piece of news about to break and more likely someone with significant funds waking up to the huge potential that will break here at some point in the near(no longer distant)future.

Trump just bought the wife an inauguration present?

Hope the rest of the day on the nasdaq continues in a continuing aforementioned pattern.

[infocusint] 20/1/2017 16:15

cautious money
Are gains exempt after 5 years.I did not know that.

[waterloo01] 20/1/2017 16:15

Any ideas as the source of the volume? Must be someone taking a position. New II about to reveal itself?

[cautiousmoney] 20/1/2017 15:12

Any thoughts on SUMM going for a full listing ??

to get clear of the casino that is AIM !

[cautiousmoney] 20/1/2017 15:10

Thanks FM1, it appears the move towards £32 may have begun

;-)

as long as they wait until February for £30 plus, that's my first tranche bought here 5 years ago, so will be tax free :-))

[curlly] 20/1/2017 14:56

Yes mega buys

[theunluckyone] 20/1/2017 14:55

Nobody noticed those two mega trades from around noon ?

[football] 20/1/2017 13:16

up in the USA last nite and the price just catching up today here

[maurillac] 20/1/2017 13:01

up 10% this am - whats occurring ?
m

[abergele] 19/1/2017 22:05

perhaps a nice end to the week for us,be a change,as still under water from my last top up..gla lth's

[chrisatrdg] 19/1/2017 21:28

NASDAQ close at 10.99 using $1.23 equates to £1.79 & which at current range on AIM of
£1.55 to £1.67 makes it ahead of AIM so can we expect a breakout in UK to follow US.

Would be good if share price in UK does follow US would be a good start to the climb back.

[freemoney1] 18/1/2017 17:13

CMO and COO
Dr Ralf Rosskamp seems very involved with the PhaseOut trial so I wouldn't expect him to be going anywhere.

I guess we might see and options RNS next to this new appointment.

It would probably show some confidence it these new guys bought some stock too.... or if the current board toped up :-)
They must be confident of a very healthy return but I guess it depends if they are sitting on news and allowed to buy right now. GLA

[deejay007] 18/1/2017 16:17

Looks a positive appointment. Is this guy below as per RNS 2/9/15 still with us - just that the roles seem to overlap ?

"Oxford, UK, 2 September 2015 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and C. difficile infection ('CDI'), today announced the appointment of Dr Ralf Rosskamp as Chief Medical Officer"

DJ

[poseidon2] 18/1/2017 12:39

Agreed Luminoso. After such a long and distinguished career one wouldn't wish to be associated with failure would one?
I reckon he knows a good thing when he sees it!!
Very happy with this.
GLA

[luminoso] 18/1/2017 12:10

Great new appointment. Francis Crick Institute. Thats the newly built monster in front of St pancras isn't it ? Well connected, I reckon.

[luminoso] 18/1/2017 11:06

I think Smmt started the year a lot lower than Summ. Now its us lagging behind a bit. Perhaps the market can't cope with the volatility of both the nasdaq trading of Smmt and the GB/USD exchange rate !

[tightfist] 18/1/2017 08:13

So..... Since 3rd Jan Nasdaq SUMM is up 20% whilst LSE SUMM is up just 3%. Very curious divergence of sentiment.

[football] 17/1/2017 20:56

nothing apart from the date sorry



History of Changes Last Updated: January 6, 2017




:(

[waterloo01] 17/1/2017 20:49

What's the change?

[football] 17/1/2017 20:41

so when will we get any news about results?






page above change today

ClinicalTrials.gov processed this record on January 17, 2017